Evolve Private Wealth’s Labcorp LH Stock Holding History

Evolve Private Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450K	Buy	1,686 +716	+74%	+$194K	0.02%	622
2025 Q4	$243K	Buy	+970	New	+$258K	0.01%	806

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Evolve Private Wealth's LH Position: Q1 2026 in Review

Evolve Private Wealth increased its Labcorp (LH) stake by 74% in Q1 2026, buying an estimated $194K and bringing the position to 1,686 shares worth $450K. The position accounts for 0.02% of the portfolio, ranked #622.

Evolve Private Wealth first reported a position in LH in Q4 2025 and has held it in 2 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Evolve Private Wealth held 1,686 shares of Labcorp worth $450K as of Q1 2026.
Evolve Private Wealth bought 716 Labcorp shares in Q1 2026, an estimated $194K.
Labcorp made up 0.02% of Evolve Private Wealth's portfolio in Q1 2026, its #622 holding.
Evolve Private Wealth first reported a position in Labcorp in Q4 2025 and has held it in 2 quarters since.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Evolve Private Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.